Nutex Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	22	34.26	36.12	0.03	1.17	0.12	0.01	0.01
Short-Term Investments	0	0	0	0	0	0	0	0.02
Cash & Cash Equivalents	22	34.26	36.12	0.03	1.17	0.12	0.01	0.03
Cash Growth	-35.77%	-5.16%	134014.16%	-97.69%	877.16%	946.75%	-58.17%	-
Receivables	62.78	58.32	114.76	0.02	0.1	0.3	0.01	0
Inventory	3.39	3.53	2.81	0	0.03	0	0	0
Other Current Assets	2.68	1.87	0.32	0.11	-0.05	-0.12	0.04	0.48
Total Current Assets	90.85	97.97	154.02	0.16	1.24	0.31	0.06	0.51
Property, Plant & Equipment	269.39	295.15	238.36	0.01	0.33	0.01	0	0
Goodwill and Intangibles	37.58	38.2	1.82	0	5.01	0	3.27	0
Other Long-Term Assets	0.43	0.42	0.46	0	0.11	0.14	0	0
Total Long-Term Assets	307.4	333.78	240.63	0.01	5.45	0.14	3.27	0
Total Assets	398.25	431.75	394.65	0.17	6.69	0.45	3.33	0.51
Accounts Payable	25.28	27.53	17.65	0.73	1.88	0.57	0.35	0.36
Deferred Revenue	0	0	0	0.08	0.17	0	0.01	0
Current Debt	20.08	21.09	13.17	0.31	2.53	0.48	0.39	0.05
Other Current Liabilities	12.96	6.24	6.86	0.04	0.03	0	0.22	5.97
Total Current Liabilities	58.31	54.86	37.69	1.15	4.61	1.04	0.96	6.38
Long-Term Debt	255.68	246.11	165.38	0.15	0.22	0.9	0	0
Other Long-Term Liabilities	5.15	10.45	0	0	0	0	0	0
Total Long-Term Liabilities	260.83	256.56	165.38	0.15	0.22	0.9	0	0
Total Liabilities	319.14	311.42	203.07	1.3	4.83	1.95	0.96	6.38
Total Debt	275.76	267.2	178.55	0.46	2.75	1.38	0.39	0.05
Debt Growth	3.20%	49.65%	38473.20%	-83.19%	99.53%	257.28%	672.38%	-
Retained Earnings	-409.07	-363.29	102.32	-18.22	-12.57	-5.45	-9.65	-10.23
Shareholders' Equity	61.45	95.86	114.65	-1.13	1.86	-1.5	2.37	-5.87
Net Cash / Debt	-253.75	-232.95	-142.43	-0.44	-1.59	-1.26	-0.37	-0.02
Net Cash Per Share	-	-	-57.24	-1.32	-6.56	-11.11	-33.60	-4.30
Working Capital	32.54	43.11	116.32	-1	-3.37	-0.74	-0.9	-5.87
Book Value Per Share	1.37	2.21	46.08	-3.44	7.68	-13.19	212.35	-1109.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).